In contrast, proliferative responses to the control antigens IA-2853-872 (T1D-associated antigen), TTX (irrelevant control) and PHA (positive control) did not differ between GAD-alum- and placebo-treated patients. Here, GAD1 is linked to type 1 diabetes mellitus.